ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Structural Control of Stromal-Immune Coupling by COL24A1 Underlies Pregnancy Maintenance.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Successful pregnancy requires dynamic extracellular matrix (ECM) remodeling at the maternal-fetal interface, yet whether individual collagen subtypes actively regulate this process remains unknown. Here, collagen type XXIV alpha 1 chain (COL24A1), a uterine-enriched fibrillar collagen, is identified as a regulator of pregnancy-associated ECM-immune homeostasis. Col24a1-deficient mice exhibit increased embryo resorption, fetal growth impairment, and pregnancy-dependent uterine collagen accumulation and inflammation. Mechanistically, Col24a1 loss promotes expansion of a maladaptive Timp1-high stromal state, accompanied by reduced matrix metalloproteinase 2 activity, impaired ECM degradation, and altered stromal-immune communication and inflammatory immune-cell states. COL24A1 silencing in human endometrial stromal cells similarly impairs decidualization and increases TIMP1 and fibrillar collagen gene expression. Hydroxychloroquine partially rescues embryo resorption and attenuates uterine inflammation, indicating that these pregnancy-associated abnormalities are pharmacologically modifiable. Moreover, a patient with 12 consecutive unexplained early pregnancy losses carrying rare heterozygous COL24A1 variants shows a concordant decidual phenotype with reduced COL24A1 and increased TIMP1, inflammation, and collagen deposition. These findings identify COL24A1 as a collagen subtype-specific regulator of maternal-fetal ECM-immune homeostasis and nominate it as a candidate susceptibility gene for unexplained recurrent pregnancy loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.